Ledger.Open graph →
SEC Form D · filed January 5, 2021

Endogena Therapeutics, Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Other
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Daniel Zabrowski · San Francisco, CADirectorMatthias Steger · San Francisco, CAExec · DirectorElona Baum · St. Paul, MNDirectorDirk Harbecke · Vancouver, British Columbia, CanadaDirectorDaniel Zabrowski · San Francisco, CADirectorMatthias Steger · San Francisco, CAExec · DirectorElona Baum · St. Paul, MNDirectorDirk Harbecke · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗